Regeneron Pharmaceuticals, Inc. (REGN) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 18.21B | 18.02B | 17.98B | 16.86B | 17.57B | 18.66B | 19.33B | 19.08B | 18.87B | 19.48B | 18.63B | 16.92B | 16.91B | 15.88B | 15.43B | 15.53B | 14.31B | 14.01B | 13.78B | 13.34B |
| Cash & Short-Term Investments | 8.75B | 8.61B | 8.44B | 7.47B | 8.35B | 9.01B | 9.8B | 9.81B | 10.52B | 10.84B | 9.91B | 8.93B | 8.96B | 7.74B | 7.02B | 7.57B | 7.05B | 5.69B | 5.79B | 3.91B |
| Cash Only | 2.96B | 3.12B | 2.51B | 2B | 3.09B | 2.49B | 2.01B | 1.92B | 2.6B | 2.73B | 2.15B | 1.94B | 3.92B | 3.11B | 3.49B | 3.4B | 3.35B | 2.89B | 3.43B | 2.07B |
| Short-Term Investments | 5.79B | 5.49B | 5.94B | 5.47B | 5.26B | 6.52B | 7.78B | 7.89B | 7.92B | 8.11B | 7.76B | 6.99B | 5.04B | 4.64B | 3.53B | 4.17B | 3.7B | 2.81B | 2.36B | 1.84B |
| Accounts Receivable | 5.73B | 5.74B | 5.69B | 5.61B | 5.56B | 6.21B | 6.11B | 5.72B | 5.22B | 5.67B | 5.58B | 5.12B | 5.12B | 5.33B | 5.55B | 5.16B | 4.84B | 6.04B | 5.45B | 7B |
| Days Sales Outstanding | 143.19 | 135.34 | 138.42 | 138.28 | 174.92 | 149.55 | 146.19 | 140.32 | 157.54 | 150.71 | 146.45 | 147.53 | 148.68 | 146.54 | 167.78 | 159.25 | 165.05 | 106.73 | 165.87 | 98.92 |
| Inventory | 3.1B | 3.2B | 3.25B | 3.21B | 3.19B | 3.09B | 3.02B | 2.87B | 2.71B | 2.58B | 2.56B | 2.51B | 2.42B | 2.4B | 2.41B | 2.22B | 1.99B | 1.95B | 2.05B | 1.98B |
| Days Inventory Outstanding | 423.81 | 507.94 | 569.71 | 549.06 | 608.63 | 496.72 | 551.85 | 529.52 | 555.42 | 376.02 | 430.43 | 441.78 | 389.94 | 436.78 | 519.04 | 515.63 | 370.25 | 174.28 | 352.84 | 246.81 |
| Other Current Assets | 0 | 474.8M | 595.6M | 574.3M | 468.9M | 349.2M | 412M | 681.9M | 414.9M | 386.6M | 574.7M | 366.3M | 406.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 22.66B | 22.54B | 22.19B | 21.36B | 19.97B | 19.1B | 18.11B | 17.01B | 15.5B | 13.6B | 13.53B | 13.73B | 13.15B | 13.33B | 12.25B | 11.68B | 12.04B | 11.42B | 9.9B | 8.15B |
| Property, Plant & Equipment | 5.27B | 5.12B | 5B | 4.84B | 4.69B | 4.6B | 4.44B | 4.31B | 4.23B | 4.15B | 4.01B | 3.92B | 3.88B | 3.76B | 3.7B | 3.64B | 3.56B | 3.48B | 3.4B | 3.36B |
| Fixed Asset Turnover | 0.69x | 0.77x | 0.76x | 0.77x | 0.65x | 0.84x | 0.85x | 0.83x | 0.75x | 0.84x | 0.85x | 0.81x | 0.83x | 0.91x | 0.80x | 0.79x | 0.84x | 1.44x | 1.02x | 1.55x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.29B | 1.26B | 1.38B | 1.35B | 1.17B | 1.15B | 1.12B | 1.1B | 1.06B | 1.04B | 1.02B | 953M | 928.7M | 915.5M | 804.1M | 0 | 0 | 6.7M | 0 | 0 |
| Long-Term Investments | 9.79B | 10.26B | 10.29B | 10.06B | 9.28B | 8.9B | 8.49B | 7.72B | 6.98B | 5.4B | 5.78B | 6.33B | 6.07B | 6.59B | 5.97B | 6.42B | 7.08B | 6.84B | 5.63B | 3.9B |
| Other Non-Current Assets | 2.13B | 1.82B | 1.67B | 1.54B | 1.39B | 1.14B | 1.04B | 993.8M | 470.2M | 444.1M | 409.9M | 393.2M | 349.6M | 336.4M | 320.2M | 269.9M | 262M | 216.1M | 145.9M | 142.9M |
| Total Assets | 40.87B | 40.56B | 40.17B | 38.22B | 37.55B | 37.76B | 37.44B | 36.09B | 34.37B | 33.08B | 32.16B | 30.66B | 30.06B | 29.21B | 27.68B | 27.21B | 26.35B | 25.43B | 23.67B | 21.49B |
| Asset Turnover | 0.09x | 0.10x | 0.10x | 0.10x | 0.08x | 0.10x | 0.10x | 0.10x | 0.09x | 0.11x | 0.11x | 0.10x | 0.11x | 0.12x | 0.11x | 0.11x | 0.11x | 0.20x | 0.15x | 0.26x |
| Asset Growth % | 8.85% | 7.41% | 7.28% | 5.91% | 9.24% | 14.14% | 16.41% | 17.71% | 14.34% | 13.23% | 16.21% | 12.69% | 14.08% | 14.86% | 16.92% | 26.62% | 48.26% | 48.19% | 47.17% | 48.91% |
| Total Current Liabilities | 5.11B | 4.37B | 4.43B | 3.67B | 3.57B | 3.94B | 3.66B | 3.51B | 3.58B | 3.42B | 3.6B | 3.1B | 3.1B | 3.14B | 2.88B | 3.03B | 3.01B | 3.93B | 3.71B | 3.73B |
| Accounts Payable | 1.03B | 939M | 903.8M | 723.9M | 705.5M | 789.5M | 497.3M | 561.7M | 671.3M | 606.6M | 536.6M | 547.3M | 599.5M | 589.2M | 535.6M | 534.2M | 470.3M | 564M | 427M | 476M |
| Days Payables Outstanding | 132.17 | 145 | 143.55 | 122.67 | 144.9 | 104.69 | 99.19 | 116.83 | 134.04 | 83.59 | 92.03 | 102.72 | 96.03 | 102.05 | 119.91 | 123.03 | 97.13 | 43.12 | 78.91 | 60.62 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 636.2M | 553M | 545.6M | 481.9M | 619.3M | 627.7M | 627.2M | 586M | 516.7M | 458.9M | 417.3M | 381.1M | 426.3M | 477.9M | 547.2M | 566.3M | 491.3M | 442M | 507.8M | 520M |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 3.57x | 4.13x | 4.06x | 4.60x | 4.93x | 4.73x | 5.28x | 5.44x | 5.27x | 5.69x | 5.18x | 5.45x | 5.45x | 5.06x | 5.36x | 5.12x | 4.76x | 3.56x | 3.71x | 3.57x |
| Quick Ratio | 2.96x | 3.39x | 3.33x | 3.72x | 4.03x | 3.95x | 4.46x | 4.62x | 4.51x | 4.94x | 4.47x | 4.64x | 4.67x | 4.29x | 4.52x | 4.39x | 4.09x | 3.07x | 3.16x | 3.04x |
| Cash Conversion Cycle | 434.83 | 498.27 | 564.58 | 564.67 | 638.65 | 541.57 | 598.84 | 553.02 | 578.93 | 443.14 | 484.85 | 486.59 | 442.58 | 481.27 | 566.91 | 551.85 | 438.18 | 237.88 | 439.8 | 285.12 |
| Total Non-Current Liabilities | 4.34B | 4.93B | 4.79B | 4.61B | 4.59B | 4.46B | 4.46B | 4.37B | 3.8B | 3.68B | 3.66B | 3.54B | 3.46B | 3.41B | 3.36B | 3.48B | 3.43B | 2.73B | 2.7B | 2.63B |
| Long-Term Debt | 1.99B | 1.99B | 1.99B | 1.99B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B | 1.98B |
| Capital Lease Obligations | 0 | 720M | 720M | 720M | 720M | 720M | 720M | 720M | 720M | 720M | 720M | 720M | 720M | 720M | 720M | 720M | 720M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.13B | 2.02B | 1.86B | 1.7B | 1.67B | 1.57B | 1.54B | 1.46B | 908.5M | 854.1M | 832.4M | 716.8M | 677.3M | 638M | 598.6M | 724.7M | 692.5M | 680.2M | 662.6M | 596.3M |
| Total Liabilities | 9.45B | 9.3B | 9.21B | 8.28B | 8.16B | 8.41B | 8.12B | 7.88B | 7.38B | 7.11B | 7.26B | 6.64B | 6.56B | 6.55B | 6.24B | 6.52B | 6.43B | 6.67B | 6.41B | 6.36B |
| Total Debt | 2.71B | 2.71B | 2.71B | 2.71B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B |
| Net Debt | -256.4M | -412.2M | 199.1M | 709.3M | -385.4M | 216.2M | 692.2M | 782.9M | 101.3M | -27.1M | 550.3M | 765M | -1.21B | -404.5M | -790.2M | -694.4M | -645.3M | -185.9M | -733.8M | 625.4M |
| Debt / Equity | 0.09x | 0.09x | 0.09x | 0.09x | 0.09x | 0.09x | 0.09x | 0.10x | 0.10x | 0.10x | 0.11x | 0.11x | 0.11x | 0.12x | 0.13x | 0.13x | 0.14x | 0.14x | 0.16x | 0.18x |
| Debt / EBITDA | 3.53x | 2.64x | 2.33x | 2.23x | 3.76x | 2.42x | 2.08x | 2.27x | 3.12x | 2.32x | 2.05x | 2.41x | 2.45x | 1.91x | 2.05x | 1.96x | 1.98x | 0.99x | 1.41x | 0.79x |
| Net Debt / EBITDA | -0.33x | -0.40x | 0.17x | 0.58x | -0.54x | 0.19x | 0.53x | 0.66x | 0.12x | -0.02x | 0.42x | 0.68x | -1.10x | -0.29x | -0.60x | -0.50x | -0.47x | -0.07x | -0.38x | 0.18x |
| Interest Coverage | 65.43x | 86.55x | 92.36x | 422.86x | 105.02x | 92.25x | 109.19x | 111.01x | 44.52x | 63.71x | 63.40x | 58.30x | 48.67x | 77.13x | 99.68x | 74.53x | 79.02x | 178.55x | 128.93x | 261.61x |
| Total Equity | 31.42B | 31.26B | 30.96B | 29.94B | 29.39B | 29.35B | 29.33B | 28.21B | 26.99B | 25.97B | 24.9B | 24.02B | 23.5B | 22.66B | 21.44B | 20.69B | 19.91B | 18.77B | 17.26B | 15.13B |
| Equity Growth % | 6.93% | 6.48% | 5.56% | 6.14% | 8.88% | 13.02% | 17.75% | 17.44% | 14.88% | 14.6% | 16.17% | 16.1% | 17.98% | 20.75% | 24.23% | 36.76% | 66.27% | 70.23% | 70.44% | 67.02% |
| Book Value per Share | 291.77 | 290.76 | 288.79 | 275.68 | 264.28 | 257.94 | 252.37 | 244.42 | 234.50 | 228.23 | 219.62 | 210.87 | 206.10 | 198.81 | 190.06 | 181.47 | 176.08 | 165.80 | 151.52 | 136.53 |
| Total Shareholders' Equity | 31.42B | 31.26B | 30.96B | 29.94B | 29.39B | 29.35B | 29.33B | 28.21B | 26.99B | 25.97B | 24.9B | 24.02B | 23.5B | 22.66B | 21.44B | 20.69B | 19.91B | 18.77B | 17.26B | 15.13B |
| Common Stock | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K |
| Retained Earnings | 36.42B | 35.8B | 35.05B | 33.68B | 32.38B | 31.67B | 30.76B | 29.41B | 27.98B | 27.26B | 26.1B | 25.09B | 24.12B | 23.31B | 22.11B | 20.79B | 19.94B | 18.97B | 16.74B | 15.11B |
| Treasury Stock | -19.41B | -18.61B | -17.94B | -17.28B | -16.22B | -15.17B | -14.19B | -13.46B | -12.86B | -12.56B | -12.27B | -11.77B | -11.05B | -10.35B | -9.91B | -9B | -8.61B | -8.26B | -7.41B | -7.22B |
| Accumulated OCI | 11.9M | 77.5M | 69M | 52.5M | 29.1M | -7.9M | 60.2M | -69.9M | -77.2M | -80.9M | -176.8M | -197.7M | -181.6M | -238.8M | -275.1M | -223.8M | -170.1M | -26.2M | 9.5M | 15.7M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |